Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $652.39 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $260.31 | 2 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $104.66 | 1 | $0 (2023) |
| Lilly USA, LLC | $96.67 | 1 | $0 (2024) |
| Stryker Corporation | $83.27 | 2 | $0 (2023) |
| Purdue Pharma L.P. | $26.03 | 2 | $0 (2018) |
| Smith & Nephew, Inc. | $24.52 | 1 | $0 (2018) |
| Daiichi Sankyo Inc. | $17.17 | 1 | $0 (2017) |
| Pacira Pharmaceuticals Incorporated | $14.33 | 1 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $12.99 | 1 | $0 (2023) |
| ERMI Inc. | $12.44 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.98 | 3 | Amgen Inc. ($260.31) |
| 2023 | $184.65 | 3 | Zimmer Biomet Holdings, Inc. ($104.66) |
| 2021 | $16.27 | 1 | Stryker Corporation ($16.27) |
| 2018 | $48.18 | 3 | Smith & Nephew, Inc. ($24.52) |
| 2017 | $46.31 | 3 | Daiichi Sankyo Inc. ($17.17) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $139.48 | General |
| 08/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $96.67 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Zimmer Biomet Holdings, Inc. | Persona (Device) | Food and Beverage | In-kind items and services | $104.66 | General |
| Category: Knees | ||||||
| 11/13/2023 | Stryker Corporation | BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION (Device) | Food and Beverage | In-kind items and services | $67.00 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 02/28/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/19/2021 | Stryker Corporation | MAKO (Device) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: KNEES, HIPS | ||||||
| 03/20/2018 | Smith & Nephew, Inc. | Topaz (Device), HEALICOIL, Q-FIX | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Other Endoscopy | ||||||
| 03/13/2018 | ERMI Inc. | — | Food and Beverage | Cash or cash equivalent | $12.44 | General |
| 01/22/2018 | Purdue Pharma L.P. | OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $11.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/05/2017 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Pain Management | ||||||
| 11/14/2017 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/17/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug), HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 306 | 2,165 | $145,598 | $71,405 |
| 2022 | 10 | 274 | 1,917 | $166,526 | $77,081 |
| 2021 | 11 | 281 | 2,920 | $210,075 | $102,704 |
| 2020 | 12 | 313 | 2,507 | $214,545 | $91,482 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 76 | 150 | $35,642 | $17,715 | 49.7% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 11 | 635 | $30,079 | $13,399 | 44.5% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 12 | 638 | $23,607 | $10,243 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 110 | $14,182 | $7,688 | 54.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 96 | $8,526 | $4,472 | 52.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $7,592 | $3,775 | 49.7% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 12 | 138 | $6,657 | $3,703 | 55.6% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 11 | 193 | $7,701 | $3,303 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 27 | $4,609 | $2,652 | 57.5% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 11 | 29 | $3,830 | $2,182 | 57.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $2,170 | $1,701 | 78.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 27 | 109 | $1,003 | $571.46 | 57.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 84 | 214 | $51,574 | $26,994 | 52.3% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 12 | 661 | $45,448 | $14,447 | 31.8% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2022 | 12 | 662 | $24,494 | $10,796 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 74 | $13,556 | $7,340 | 54.1% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 12 | 58 | $10,382 | $6,146 | 59.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 31 | 86 | $7,569 | $3,958 | 52.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $7,128 | $3,729 | 52.3% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2022 | 11 | 34 | $4,655 | $2,706 | 58.1% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 13 | 19 | $860.00 | $511.44 | 59.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 24 | 85 | $860.00 | $453.93 | 52.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 99 | 292 | $62,678 | $35,521 | 56.7% |
| 97112 | Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2021 | 16 | 942 | $50,466 | $21,375 | 42.4% |
| 97140 | Manual (physical) therapy techniques to 1 or more regions, each 15 minutes | Office | 2021 | 16 | 933 | $40,184 | $15,991 | 39.8% |
About Dr. Jeffrey Newfield, DO
Dr. Jeffrey Newfield, DO is a Orthopaedic Surgery healthcare provider based in Ormond Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922191667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Newfield, DO has received a total of $652.39 in payments from pharmaceutical and medical device companies, with $356.98 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($652.39).
As a Medicare-enrolled provider, Newfield has provided services to 1,174 Medicare beneficiaries, totaling 9,509 services with total Medicare billing of $342,672. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Other Specialties Foot and Ankle Surgery
- Location Ormond Beach, FL
- Active Since 10/02/2006
- Last Updated 06/29/2010
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1922191667
Products in Payments
- Repatha (Biological) $120.83
- Persona (Device) $104.66
- MOUNJARO (Drug) $96.67
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION (Device) $67.00
- OXYCONTIN (Drug) $26.03
- Topaz (Device) $24.52
- Morphabond ER (Drug) $17.17
- MAKO (Device) $16.27
- EXPAREL (Drug) $14.33
- SEGLENTIS (Drug) $12.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Ormond Beach
Kenneth Hawthorne, Md, MD
Orthopaedic Surgery — Payments: $231.11
Dr. Robert Hatch, M.d, M.D
Orthopaedic Surgery — Payments: $21.34
Dr. Aron Newfield, Do, DO
Orthopaedic Surgery
James Acker, Md, MD
Orthopaedic Surgery